Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

157 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Enhanced albumin uptake by rat tumors.
Wunder A, Stehle G, Sinn H, Schrenk H, Hoffbiederbeck D, Bader F, Friedrich E, Peschke P, Maierborst W, Heene D. Wunder A, et al. Int J Oncol. 1997 Sep;11(3):497-507. doi: 10.3892/ijo.11.3.497. Int J Oncol. 1997. PMID: 21528238
Antitumor activity of methotrexate-albumin conjugates in rats bearing a Walker-256 carcinoma.
Wunder A, Stehle G, Schrenk HH, Hartung G, Heene DL, Maier-Borst W, Sinn H. Wunder A, et al. Int J Cancer. 1998 Jun 10;76(6):884-90. doi: 10.1002/(sici)1097-0215(19980610)76:6<884::aid-ijc19>3.0.co;2-2. Int J Cancer. 1998. PMID: 9626357
Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
Hartung G, Stehle G, Sinn H, Wunder A, Schrenk HH, Heeger S, Kränzle M, Edler L, Frei E, Fiebig HH, Heene DL, Maier-Borst W, Queisser W. Hartung G, et al. Clin Cancer Res. 1999 Apr;5(4):753-9. Clin Cancer Res. 1999. PMID: 10213209 Clinical Trial.
Pharmacokinetics of methotrexate-albumin conjugates in tumor-bearing rats.
Stehle G, Wunder A, Sinn H, Schrenk HH, Schütt S, Frei E, Hartung G, Maier-Borst W, Heene DL. Stehle G, et al. Anticancer Drugs. 1997 Oct;8(9):835-44. doi: 10.1097/00001813-199710000-00004. Anticancer Drugs. 1997. PMID: 9402310
Plasma protein (albumin) catabolism by the tumor itself--implications for tumor metabolism and the genesis of cachexia.
Stehle G, Sinn H, Wunder A, Schrenk HH, Stewart JC, Hartung G, Maier-Borst W, Heene DL. Stehle G, et al. Crit Rev Oncol Hematol. 1997 Jul;26(2):77-100. doi: 10.1016/s1040-8428(97)00015-2. Crit Rev Oncol Hematol. 1997. PMID: 9298326 Review. No abstract available.
Pharmacokinetic properties of LMW-heparin-tyramine fractions with high or low affinity to antithrombin III in the rat.
Stehle G, Wunder A, Sinn H, Schrenk HH, Harenberg J, Malsch R, Maier-Borst W, Heene DL. Stehle G, et al. Semin Thromb Hemost. 1997;23(1):31-7. doi: 10.1055/s-2007-996067. Semin Thromb Hemost. 1997. PMID: 9156408
157 results
Jump to page
Feedback